TrialClinical trialPHN-02972026-10-06 19:00 CT
Vicia Faba Peptides and Resistance Training in the Elderly
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A ClinicalTrials.gov listing describes a randomized, double-blind, placebo-controlled trial of Vicia faba L.-derived peptides combined with resistance training in approximately 100 adults aged 60 or older. The study is enrolling by invitation and will assess physical, cognitive, and quality-of-life outcomes.
01—Key points
- 01Researchers will compare peptide supplementation with placebo, with both groups receiving supervised resistance training and nutritional monitoring.
- 02Assessments before and after the four-week intervention will include strength, body composition, mobility, frailty, and cognitive performance.
- 03The study will examine whether habitual physical activity affects responses; no results are reported in the excerpt.
Why it matters Editorial
The trial will investigate whether plant-derived peptides add benefits to resistance training in older adults.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.